CERE
Cerevel Therapeutics Holdings Inc
Price:  
44.96 
USD
Volume:  
15,090,400.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CERE Stock Forecast & Price Target

CERE Stock Price Forecast

The average stock forecast for Cerevel Therapeutics Holdings Inc (CERE) in the next 12 months is 44.27 USD. This price target corresponds to an upside of -1.54%. The range of stock forecasts for CERE is 31.31 - 47.25 USD. Based on the ratings of 14 analysts, the consensus recommendation for CERE is HOLD.
Target Low Average Median High
Price (USD) 31.31 44.27 45.90 47.25
Upside -30.36% -1.54% 2.09% 5.09%

Recommendation Trends

The latest consensus rating for CERE is "HOLD". This is the average recommendation of 14 analysts: 2 strong sell, 1 sell, 11 hold, 0 buy, 0 strong buy. In the previous period, 14 analysts also majorly recommmended "HOLD" for CERE.

CERE Financial Stock Forecast

Revenue This Year
-M
from -M
Revenue Next Year
-M
from -M
EPS This Year
-2.59
9.04%
from -2.38
EPS Next Year
-2.88
11.33%
from -2.59